Business · 06/06/2011Updated: 10/17/2026 · 1 min read
FDA Corrects Draft Guidance on Financial Disclosure by Clinical Investigators
Summary
The Food and Drug Administration (FDA) has corrected a notice regarding the availability of a draft guidance on financial disclosure by clinical investigators, which was published with an incorrect docket number and originally announced on May 24, 2011.
Original source language: Federal Register — Health and Human ServicesOpen original release →